Cases of this eye condition are expected to increase around the world to 22 million by the year 2040. The key to holding onto your vision is getting diagnosis and treatment early.
Glaucoma affects peripheral vision, creating blind spots in the outer edges of a person’s visual field. This can affect daily activities such as driving and walking. Glaucoma is the name for a group ...
There are typically no visual changes in the initial stages of glaucoma. As damage occurs to the optic nerve, people may develop blind spots in their peripheral visual field. Some can see halos and ...
Glaucoma is the term for a group of eye conditions that damage the optic nerve at the back of the eye. Without treatment, it can lead to vision loss and blindness. Glaucoma is not a life threatening ...
This transcript has been lightly edited for clarity; captions are auto-generated.
Glaucoma is a group of eye conditions that can lead to vision loss. Health experts are unsure of the exact cause of glaucoma. When a person has glaucoma, fluid does not properly drain out of the eye.
Please provide your email address to receive an email when new articles are posted on . Glaucoma patients deserve the best level of care, and this includes any new technologies that allow them to ...
The risk of developing glaucoma can be influenced mostly by an individual's body weight and overall physical health. Read on to know more about this condition. TheHealthSite.com ...
Charisse Brown, a 38-year-old Columbia, S.C., resident, talks about her journey with glaucoma and keratoconus, which led to vision loss in her left eye. Underinsured and not qualifying for Medicaid, ...
Université de Montréal provides funding as a founding partner of The Conversation CA-FR. Université de Montréal provides funding as a member of The Conversation CA. Like high blood pressure, glaucoma ...
A form of gene therapy protects optic nerve cells and preserves vision in mouse models of glaucoma, according to new research. The findings suggest a way forward for developing neuroprotective ...